AGM
RIGL icon

Alpine Global Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Alpine Global Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,287
Closed -$16.6K – 220
2023
Q2 		$16.6K Buy
+1,287
New +$17.4K ﹤0.01% 190
2023
Q1 		– Sell
-3,584
Closed -$54K – 362
2022
Q4 		$54K Buy
+3,584
New +$32.9K 0.02% 395
2019
Q1 		– Sell
-1,013
Closed -$23K – 189
2018
Q4 		$23K Buy
+1,013
New +$28.6K 0.01% 229

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alpine Global Management's RIGL Position: Q3 2023 in Review

Alpine Global Management sold out of Rigel Pharmaceuticals (RIGL) in Q3 2023, closing a stake of 1,287 shares — an estimated $16.6K sold.

Alpine Global Management first reported a position in RIGL in Q4 2018 and held it in 3 quarters. The position peaked at $54K in Q4 2022. 106 funds tracked by Wall St. Rank hold RIGL as of Q3 2023.

  • Alpine Global Management reported no remaining Rigel Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Alpine Global Management sold 1,287 Rigel Pharmaceuticals shares in Q3 2023, an estimated $16.6K.
  • Alpine Global Management first reported a position in Rigel Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • Alpine Global Management's Rigel Pharmaceuticals position peaked at $54K in Q4 2022.
  • 106 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2023.

Based on Alpine Global Management's 13F filing for Q3 2023, filed 14 Nov 2023.